Communications publiées lors de congrès ou colloques nationaux et internationaux (8)
5.
Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2016). Development of siRNA-loaded Chitosan Nanoparticles targeting Galectin-1 for the Treatment of Glioblastoma Multiforme via Intranasal Administration. Respiratory Drug Delivery 2016. Vol. 3 (pp. 573-578) Respiratory Drug Delivery(17-21/04/2016: Phoenix Arizona).6.
Rosiere, R., Amighi, K., & Wauthoz, N. (2015). New Dry Powders for Inhalation Containing Chitosan Derivative-Coated Solid Lipid Nanoparticles for Targeted Delivery to Lung Cancer Cells. In R. R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2015 (pp. 447-452). (book 2). USA: Virginia Commonwealth University.7.
Rosiere, R., Wauthoz, N., Van Antwerpen, P., Gelbcke, M., & Amighi, K. (2014). Development of Folate Receptor-Targeted Nanoparticles Containing Temozolomide for Lung Cancer Therapy by Dry Powder Inhalation. In R. R. N. Dalby, P. R. Byron, J. Peart, S. J. Farr, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD 2014 Puerto Rico (pp. 609-612). (book 3). USA: Virginia Commonwealth University.8.
Duret, C., Wauthoz, N., Rosiere, R., Sebti, T., Vanderbist, F., & Amighi, K. (2013). Prophylactic Efficacy of Inhaled Itraconazole-Mannitol Dried Solid Dispersion Against Invasive Pulmonary Aspergillosis. In R. R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2013 (pp. 383-388). (book 2). USA: Virginia Commonwealth University. Participations à des congrès et colloques internationaux (17)
1.
Wauthoz, N., Chraibi, S., Davenne, T., Gérard, P., Rosiere, R., & Amighi, K. (2022). Evaluation of Tumour Exposure following the Administration of an Innovative Cisplatin Dry Powder for Inhalation at Different Dose Levels and Regimens. Paper session presented at Drug Delivery to the Lung (2022: 7-9th December 2022: Edinburg).2.
Chraibi, S., Rosiere, R., De Prez, E., Langer, I., Nortier, J., Amighi, K., & Wauthoz, N. (2021). Evaluation of pulmonary and renal tolerance on mice of a cisplatin-based dry powder for inhalation to treat lung cancer. Poster présenté à la conférence Pharmaceutics, Biopharmaceutis and Pharmaceutical Technology (12th: 11-14th May 2021: Digital).3.
Chraibi, S., De Prez, E., Rosiere, R., Touzani, F., Antoine, M.-H., Wauthoz, N., Amighi, K., & Nortier, J. (2020). Évaluation préclinique de la tolérance rénale suite à l’administration par voie systémique et par inhalation de cisplatine dans un modèle murin de cancer pulmonaire. Paper session presented at congrès de la société francophone de néphrologie, dialyse et transplantation (SFNDT) (5ème: 07/10/2020-08/10/2020: Digital).4.
Chraibi, S., Rosiere, R., Larbanoix, L., Laurent, S., De Prez, E., Nortier, J., Amighi, K., & Wauthoz, N. (2020). Optimization of Cisplatin-based Regimens Combining Pulmonary and Intravenous Routes for Lung Cancer Therapy. Poster présenté à la conférence Respiratory Drug Delivery 2020 (26/04/2020-30/06/2020).5.
Rosiere, R., Bischof, R., Chraibi, S., Hennia, I., Meeusen, E., Amighi, K., & Wauthoz, N. (2020). Pharmacokinetic and Preliminary Toxicity Investigation of an Innovative Controlled-Release Cisplatin Dry Powder Inhalation Formulation in Sheep. Poster présenté à la conférence Respiratory Drug Delivery 2020 (26/04/2020-30/06/2020: Digital).6.
Rosiere, R., Chraibi, S., Albasry, S., Vermeech, M., Amighi, K., & Wauthoz, N. (2017). Development of paclitaxel nanocrystal-based dry powder formulations for targeted therapy of lung tumours by inhalation. Poster présenté à la conférence Drug Delivery to the lungs (DDL) (28: 2017-12-06-08: Edimbourg).7.
Rosiere, R., Van Woensel, M., Mathieu, V., Mathivet, T., Amighi, K., & Wauthoz, N. (2016). New lung-tumour-penetrating nanocarrier designed for aerosolized chemotherapy. Paper session presented at Drug Delivery to the lung (27th world meeting: 7-9/12/2016: Edinburg (UK)).